![Christopher Cain](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Cain
Direktor/Vorstandsmitglied bei
COGENT BIOSCIENCES, INC.
Vermögen: - $ am 31.05.2026
Profil
Christopher Cain is currently an Independent Director at Cogent Biosciences, Inc. since 2020.
Dr. Cain is also an Independent Director at Damora Therapeutics, Inc., Viridian Therapeutics, Inc., and Jade Biosciences, Inc. starting in 2025.
Additionally, Dr. Cain serves as a Director at Jade Biosciences, Inc. (United States) since 2024.
Formerly, Dr. Cain was Vice President at Samsara BioCapital LP from 2019 to 2020.
Prior to that, Dr. Cain was Senior Associate at Apple Tree Venture Management LLC from 2016 to 2019.
Dr. Cain completed undergraduate studies at the University of California, Santa Barbara in 2004 and earned a doctorate from the University of California, San Francisco in 2010.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 09.06.2026 | 0 ( -.--% ) | - $ | 31.05.2026 | |
| 31.03.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Christopher Cain
| Unternehmen | Position | Beginn |
|---|---|---|
| COGENT BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 06.07.2020 |
| VIRIDIAN THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 10.03.2025 |
| JADE BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 28.04.2025 |
| DAMORA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 10.11.2025 |
Ehemalige bekannte Positionen von Christopher Cain
| Unternehmen | Position | Ende |
|---|---|---|
Samsara BioCapital LP
 Samsara BioCapital LP Investment ManagersFinance Acts as Venture Capital Fund | Corporate Officer/Principal | 01.02.2020 |
Apple Tree Venture Management Llc//vc
 Apple Tree Venture Management Llc//vc Investment ManagersFinance Apple Tree Partners invests in companies located in the United States. The firm focuses on the life sciences sector. It provides financing for seed, early and later stage capital requirements. | Private-Equity-Analyst | 28.02.2019 |
Ausbildung von Christopher Cain
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
82
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Cogent Biosciences, Inc.
 Cogent Biosciences, Inc. BiotechnologyHealth Technology Discovers and develops new cellular immunotherapies for cancer | Health Technology |
University of California, Santa Barbara
 University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Apple Tree Venture Management Llc//vc
Apple Tree Venture Management Llc//vc Investment ManagersFinance Apple Tree Partners invests in companies located in the United States. The firm focuses on the life sciences sector. It provides financing for seed, early and later stage capital requirements. | Finance |
Viridian Therapeutics, Inc.
 Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products | Health Technology |
Samsara BioCapital LP
Samsara BioCapital LP Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Galecto, Inc.
 Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases | Health Technology |
Aerovate Therapeutics, Inc.
 Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
